Stocks
Allogene Therapeutics (ALLO) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -29.3% | -21.6% | -26.7% | -49.5% | -63.9% | -61.1% | ||
| Changes by years, y/y, % | +1pp | +8pp | -5pp | -23pp | -14pp | +16.3% | |||
Allogene Therapeutics. ROE, %
Allogene Therapeutics. ROE, changes, pp
Allogene Therapeutics (ALLO) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -56.8% | -63.1% | -62.9% | -54.1% | -61.1% | -61.1% | |
| Changes by years, y/y, % | -15pp | -14pp | -4pp | +2pp | -4pp | |||
| Changes by quarters, q/q, % | 0pp | -6pp | +0pp | +9pp | -7pp | |||
